who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

CNC · Q2 2026

Archived report (Q2 2026). Latest deep dive →

US GAAP, Q2 2026 · quarter ended 06/30/2026 · released Jul 28

The quarter in brief

Revenue grew 9.9% y⁠/⁠y to $53.58B, operating margin 2.2% vs −0.9%, net income $1.09B.

Net earnings (loss) attributable to Centene Corporation

$1,091M

Total revenues

$53,579M

up 9.9% y/y

Earnings (loss) from operations

$1,198M

All figures in $M.

Sankey diagram of CNC earnings report for Q2 2026: revenue, costs and profitPremium$43,582 · +4.4%Service$793 · +9.1%Premium tax$9,204 · +46.7%Total revenues$53,579 · +9.9%Cost of services$729 · +13.7%Medical costs$39,029 · +0.6%Selling, generalandadministrativeexpenses$3,103 · +2.2%Depreciationexpense$139 · −1.4%Amortization ofacquiredintangible assets$161 · −6.9%Premium taxexpense$9,220 · +45.3%Earnings (loss)from operations$1,198 · vs −$4582.2% marginInvestment andother income$435 · +17.3%Gain on debtextinguishment$6 · vs $0Interest expense$153 · −10.0%Earnings (loss)before income tax$1,486 · vs −$257Income tax expense$399 · ×20026.9% effective rateLoss attributable tononcontrolling interests$4 · −33.3%Net earnings (loss)attributable to CenteneCorporation$1,091 · vs −$253$2.19/sh · 2.0% margin
Sankey diagram of CNC earnings report for Q2 2026: revenue, costs and profit
Line itemAmount and change
Premium$43,582 · +4.4%
Service$793 · +9.1%
Premium tax$9,204 · +46.7%
Total revenues$53,579 · +9.9%
Cost of services$729 · +13.7%
Medical costs$39,029 · +0.6%
Selling, general and administrative expenses$3,103 · +2.2%
Depreciation expense$139 · −1.4%
Amortization of acquired intangible assets$161 · −6.9%
Premium tax expense$9,220 · +45.3%
Earnings (loss) from operations$1,198 · vs −$458 · 2.2% margin
Investment and other income$435 · +17.3%
Gain on debt extinguishment$6 · vs $0
Interest expense$153 · −10.0%
Earnings (loss) before income tax$1,486 · vs −$257
Income tax expense$399 · ×200 · 26.9% effective rate
Loss attributable to noncontrolling interests$4 · −33.3%
Net earnings (loss) attributable to Centene Corporation$1,091 · vs −$253 · $2.19/sh · 2.0% margin

Verdict: revenue grew 9.9% y/y to $53.58B, operating margin 2.2% vs −0.9%, net income $1.09B.

Source and notation

Source: Centene press release, 8-K EX-99.1 of 07/28/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.

Open as an image: CNC, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line
Chart: “CNC Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/cnc/q2-2026. Licensed under CC BY 4.0.
HTML: image with link and credit
<figure>
  <a href="https://whoreportstoday.com/t/cnc/q2-2026"><img src="https://whoreportstoday.com/t/cnc/q2-2026/sankey.png" alt="CNC Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/cnc/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>
Direct link to the image (PNG)
https://whoreportstoday.com/t/cnc/q2-2026/sankey.png
Link for your article text
<a href="https://whoreportstoday.com/t/cnc/q2-2026">CNC Q2 2026 earnings chart (Who Reports Today)</a>

This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

CNC — a health insurer focused on government-sponsored and low-income coverage: it runs state Medicaid plans, Medicare Advantage and Part D drug plans, and individual policies sold through the Health Insurance Marketplace.

It reports four segments: Medicaid, Medicare, Commercial and Other (specialty pharmacy, vision, dental and behavioral health); Medicaid accounted for 57% of 2025 revenue. · Source: annual report (Form 10-K, SEC)

More reports: COO · Q3 FY2026 · COR · Q3 FY2026 · CRL · Q2 2026 · CVS · Q2 2026 · DGX · Q3 2026 · DHR · Q3 2026 · DVA · Q2 2026 · DXCM · Q2 2026 · ELV · Q3 2026 · EW · Q2 2026 · all reports

Company reports

Q3 2026latest breakdownRevenue grew 1.9% y/y to $50.65B, operating margin −0.6% vs −14.0%, net loss $71M (vs net loss $6.63B a year earlier).
Q2 2026Revenue grew 9.9% y/y to $53.58B, operating margin 2.2% vs −0.9%, net income $1.09B.

Cookies the site needs and, with your consent, Google Analytics — privacy policy